Editorial Board & Research Correspondence
human-growth-hormone-hgh.net is an independent endocrinology and sports pharmacology archival publication maintained since October 2002. For inquiries regarding HPLC assay documentation or historical monographs, navigate our complete articles directory or site map.
1. Editorial Governance, Peer Review & Archival Preservation Standards
Founded in October 2002 as an independent digital reference repository for clinical endocrinology and recombinant polypeptide pharmacology, human-growth-hormone-hgh.net maintains strict editorial separation between historical monograph preservation and analytical laboratory verification. Every technical dossier published across our 14-page domain is reviewed by our European Somatropin & Peptide Working Group—comprising analytical chemists specializing in liquid chromatography, sports medicine researchers, and clinical endocrinology editors across the DACH (Germany, Austria, Switzerland) and European Union regions.
Our archival mandate serves two complementary objectives: first, preserving the original URL architecture and peer-referenced medical educational content that earned citations across European health and athletics forums over two decades; second, updating outdated 2000s-era dosing claims and discontinued underground kit profiles with modern 2026 European Pharmacopoeia (Ph. Eur. 11.0) quality standards and verified third-party SEC-HPLC assay data.
2. Submitting Analytical Chromatograms (SEC-HPLC / RP-HPLC) for Review
Researchers, compounding pharmacists, and independent harm-reduction testing initiatives wishing to submit third-party laboratory certificates (such as Janoshik Analytical, Analiza Bialek, or university mass-spectrometry reports) for inclusion in our kit comparison tables must ensure that submitted documentation satisfies our four-point analytical verification protocol. Unverified manufacturer claims or certificates lacking verifiable cryptographic task keys are never indexed in our clinical monographs.
Editorial & Analytical Verification Requirements Matrix
| Submission Category | Required Analytical Documentation | Minimum Acceptance Standard | Editorial Review Turnaround |
|---|---|---|---|
| Lyophilized Somatropin Kit Assay | SEC-HPLC + RP-HPLC Chromatogram with Public Verification Key | ≥ 98.0% Monomeric Purity; < 1.5% Dimer Fraction; ±5% Mass Accuracy | 5 – 7 Business Days |
| Liquid Cartridge Stability Data | Time-Zero vs. 30-Day Refrigerated (2–8°C) SEC-HPLC Comparison | ≤ 1.0% Dimer Increase over 28 Days in Metacresol/Phenol Buffer | 7 – 10 Business Days |
| Clinical Monograph Errata / Citations | PubMed PMID / DOI Reference from Peer-Reviewed Endocrinology Journal | Randomized Controlled Trial (RCT), Meta-Analysis, or Endocrine Society Guideline | 3 – 5 Business Days |
| Counterfeit Batch Alert (EU/DACH) | High-Resolution Vial Photography + Qualitative hCG/Mass Spec Test | Confirmed 192-AA Somatrem, hCG Substitution, or Severe Underdosing (<50% claim) | 24 – 48 Hours (Priority Harm-Reduction Alert) |
3. Medical Disclaimer & Non-Clinical Correspondence Policy
Please note that the editorial board of human-growth-hormone-hgh.net operates strictly as an informational, scientific, and harm-reduction publishing library. We do not manufacture, compound, or directly dispense prescription pharmaceuticals from this domain, nor can our editorial staff provide individualized medical diagnoses or patient-specific prescriptions via email.
Individuals suspecting clinical Adult Growth Hormone Deficiency (AGHD) or pituitary pathology should consult a board-certified endocrinologist to arrange dynamic pituitary stimulation testing (Insulin Tolerance Test or Macimorelin/GHRH-Arginine testing) and baseline magnetic resonance imaging (MRI) of the sella turcica.
- Archival Indexing & Citation Format: When citing monographs from this repository in academic or athletic harm-reduction literature, reference the canonical URL and specify the latest 2026 SEC-HPLC revision cycle.
- Batch Verification Inquiries: Before inquiring about a specific European Somatropin brand (such as Hilma Biocare, Somatrop-Lab, or Driada Medical), check the batch verification portals and current HPLC lab test dossiers hosted at SteroidsEU (International HGH Catalog) or SteroidsEU Deutschland.
- Language Support: Editorial correspondence and analytical lab submissions are accepted in both English and German (DACH Working Group).
All archival revisions undergo dual-stage technical verification to ensure that chromatographic retention times, molecular weight calculations (22,124 Da for monomeric 191-amino-acid Somatropin), and bacteriostatic reconstitution tables align with current European Pharmacopoeia (Ph. Eur. 11.0) analytical specifications.